Continuous intrathecal administration of short-lasting μ opioids remifentanil and alfentanil in the rat

Anesthesiology

Volumn 84, Issue 4, 1996, Pages 926-935

  Buerkle, Hartmut ^a,b   Yaksh, Tony L ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Allgemeines Krankenhaus Eilbek   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Analgesics: opioid: alfentanil; remifentanil; Complications: motor function; Side effects: spinal; supraspinal; Vehicles: glycine

Indexed keywords

3 [4 METHOXYCARBONYL 4 (N PHENYLPROPIONAMIDO)PIPERIDINO]PROPIONIC ACID; ALFENTANIL; GR 90291A; MU OPIATE RECEPTOR; NALOXONE; OPIATE AGONIST; REMIFENTANIL; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THERMAL STIMULATION; WITHDRAWAL REFLEX;

ALFENTANIL; ANALGESIA; ANALGESICS, OPIOID; ANIMALS; INJECTIONS, SPINAL; MALE; MOTOR ACTIVITY; NALOXONE; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; SPINAL CORD;

EID: 0029865407     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199604000-00021     Document Type: Article

References (19)

1. James MK, Feldman PL, Schuster SV, Bilotta JM, Brackeen MF, Leighton HJ: Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues. J Pharmacol Exp Ther 1991; 259:712-8
2. Shlugman D, Dufore S, Dershwitz M, Rosow C, Glass PSA: Respiratory effects of remifentanil in subjects with severe renal impairment compared to matched controls (abstract). ANESTHESIOLOGY 1994; 81:A1417
3. Dershwitz M, Rosow CE, Michalowski P, Connors PM, Hoke JF, Muir KT, Dienstag JL: Pharmacokinetics and pharmacodynamics of rcmifentanil in volunteer subjects with severe liver disease compared with normal subjects (abstract). ANESTHESIOLOGY 1994; 81:A377
4. Westmoreland CL, Hoke JF, Sebel PS, Hug C Jr., Muir KT: Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. ANESTHESIOLOGY 1993; 79:893-903
5. Egan TD, Lemmens HJ, Fiset P, Hermann DJ, Muir KT, Stanski DR, Shafer SL: The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. ANESTHESIOLOGY 1993; 79:881-92
6. Glass PS, Hardman D, Kamiyama Y, Quill TJ, Marton G, Donn KH, Grosse CM, Hermann D: Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: Remifentanil (GI87084B). Anesth Analg 1993; 77:1031-40
7. Sabbe MB, Graf MR, Mjanger E, Tiseo PJ, Hill HF, Yaksh TL: Spinal delivery of sufentanil, alfentanil and morphine in dogs. ANESTHESIOLOGY 1994; 81:899-920
8. Yaksh TL, Noueihed RY, Durant PA: Studies of the pharmacology and pathology of intrathecally administered 4-anilinopiperidine analogues and morphine in the rat and cat. ANESTHESIOLOGY 1986; 64: 54-66
9. Payne R: CSF distribution of opioids in animals and man Acta Anaesthesiol Scand Suppl 1987; 85:38-46
10. Caldwell LE, Rosen MA, Shnider SM: Subarachnoid morphine and fentanyl for labor analgesia. Efficacy and adverse effects. Reg Anesth 1994; 19:2-8
11. Buerkle H, Yaksh TL: Comparison of the spinal actions of the μ opioid remifentanil with alfentanil and morphine in the rat. ANESTHESIOLOGY 1996; 84:94-102
12. Yaksh TL, Rudy TA: Analgesia mediated by a direct spinal action of narcotics. Science 1976; 192:1357-8
13. Dirig DM, Yaksh TL: Differential right shifts in the dose response curve for intrathecal morphine and sufentanil as a function of stimulus intensity. Pain 1995; 62:321-8
14. Hargreaves K, Dubner R, Brown F, Flores C, Joris J: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32:77-8
15. Boersma FP, Meert TF, Vercauteren M: Spinal sufentanil in rats: Part I: Epidural versus intrathecal sufentanil and morphine. Acta Anaesthesiol Scand 1992; 36:187-92
16. Tallarida RJ, Murray RB: Manual of Pharmacologic Calculations with Computer Programs, 2. New York, Springer, 1986
17. Araki T, Yamano M, Murakami T, Wanaka A, Betz H, Tohyama M: Localization of glycine receptors in the rat central nervous system: An immunocytochemical analysis using monoclonal antibody Neuroscience 1992; 25:613-24
18. Hall PV, Smith JE, Lane J, Mote T, Campbell R: Glycine and experimental spinal spasticity. Neurology 1979; 29:262-7
19. Simpson RK, Robertson CS, Goodman JC: Glycine: An important component of spinal shock. Neurochem Res 1993; 18:887-92